ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

MEDS TRxADE HEALTH Inc

6.29
0.28 (4.66%)
May 03 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
TRxADE HEALTH Inc MEDS NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.28 4.66% 6.29 23:00:02
Open Price Low Price High Price Close Price Previous Close
6.02 6.02 6.42 6.29 6.01
more quote information »

Recent News

Date Time Source Heading
4/23/202415:05GLOBETRxADE Health, Inc. Announces Receipt of Notice from Nasdaq..
3/06/202407:30EDGAR2Form 8-K - Current report
3/06/202407:05GLOBETRxADE Health, Inc. Announces Special Cash Dividend
2/26/202411:00EDGAR2Form SEC STAFF ACTION - SEC Staff Action: ORDER
2/16/202416:05EDGAR2Form 8-K - Current report
2/14/202413:50EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
1/17/202408:07GLOBETrxade health, Inc files its 3Q 10Q
1/17/202408:05EDGAR2Form 8-K - Current report
1/16/202415:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
1/16/202405:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/11/202416:25EDGAR2Form 8-K - Current report
11/29/202317:13GLOBETRxADE Announces Receipt of Notification of Deficiency from..
11/28/202311:29EDGAR2Form 8-K - Current report
11/15/202312:51EDGAR2Form NT 10-Q - Notification of inability to timely file Form..
10/17/202307:05GLOBETrxADE Health, Inc. affirms its commitment to the..
10/13/202312:25EDGAR2Form 8-K - Current report
10/12/202307:05GLOBESuperlatus Announces Distribution Partnership with North..
10/11/202315:05EDGAR2Form 8-K - Current report
10/04/202308:29EDGAR2Form 8-K - Current report
10/04/202307:05GLOBESuperlatus, Newly Merged with TRxADE HEALTH, Acquires the..
9/25/202307:06EDGAR2Form PRER14A - Preliminary Proxy Soliciting materials
9/14/202316:28EDGAR2Form 8-K - Current report
9/08/202309:42EDGAR2Form PRER14A - Preliminary Proxy Soliciting materials
9/07/202307:05GLOBESuperlatus Announces Planned Expansion into Pet Food Market
8/25/202305:15EDGAR2Form 8-K - Current report
8/24/202308:47EDGAR2Form 8-K - Current report
8/24/202307:05GLOBESuperlatus Innovates $151 Billion US Snacking Market with..
8/22/202307:05GLOBESuperlatus, Newly Merged with TRxADE HEALTH, Agrees to..
8/18/202315:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/14/202309:25GLOBETRxADE HEALTH, Inc. Announces Extension of Form 10-Q Filing
8/14/202307:30EDGAR2Form NT 10-Q - Notification of inability to timely file Form..
8/14/202305:20EDGAR2Form PRE 14A - Other preliminary proxy statements
8/03/202308:05GLOBENewly merged Entity Superlatus, Inc with Trxade Health, Inc...
7/31/202308:40EDGAR2Form 8-K - Current report
7/31/202307:35GLOBETRxADE HEALTH, Inc. Announces Closing of Acquisition of..
7/14/202316:08EDGAR2Form 425 - Prospectuses and communications, business..
7/14/202316:07EDGAR2Form 8-K - Current report
7/14/202315:30GLOBETRxADE HEALTH, Inc. Amends Definitive Merger Agreement with..
7/10/202315:58EDGAR2Form 8-K - Current report
6/30/202308:25EDGAR2Form 425 - Prospectuses and communications, business..
6/30/202308:25EDGAR2Form 8-K - Current report
6/30/202307:05GLOBESuperlatus, Inc. and TRxADE HEALTH, Inc. Sign Definitive..
6/27/202307:00GLOBESuperlatus, Inc. Announces New Appointments to the..
6/23/202315:40GLOBETRxADE HEALTH, Inc. Issues Correction to Press Release..
6/23/202307:05GLOBESuperlatus, Inc. to Combine with TRxADE HEALTH, Inc., to..
6/21/202311:36GLOBETRxADE Health, Inc.’s Board of Directors Approves Reverse..
5/15/202315:15GLOBETRxADE HEALTH Reports First Quarter Gross Margin of 69% and..

Your Recent History

Delayed Upgrade Clock